Latka logo

AI-MED Co. revenue, CEO Madan Rao, team size, customer count, churn, and more in 2026.

AI -MED stands out as a pioneer start-up in developing of Artificial Intelligence based medical models

AI-MED Co. Revenue

We do not have information about AI-MED Co.'s revenue yet.

AI-MED Co. Valuation, Funding Rounds

Explore the complete funding history and valuation milestones for this company. Below you will find information about each funding round and key financial metrics that shaped the company's growth trajectory.

AI-MED Co. Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$120202020 cumulative: $0 • 2020 Founded: $02020 Founded: $0 valuationSource: GetLatka.com
YearRoundAmountValuation% Sold

AI-MED Co. Employees & Team Size

We do not have information about AI-MED Co.'s team yet.

Founder / CEO

Madan Rao

Madan Rao is listed as Founder / CEO at AI-MED Co..

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for AI-MED Co. yet.

Frequently Asked Questions about AI-MED Co.

What is AI-MED Co.'s revenue?

GetLatka has not confirmed a public revenue figure for AI-MED Co..

Who is the CEO of AI-MED Co.?

The CEO of AI-MED Co. is Madan Rao.

How much funding does AI-MED Co. have?

AI-MED Co. raised -.

How many employees does AI-MED Co. have?

AI-MED Co. has - employees.

Where is AI-MED Co. headquarters?

AI-MED Co. is headquartered in Péchabou, Occitanie, France.

Compare AI-MED Co. to the industry

AI-MED Co. operates across multiple industries. Browse revenue, funding, and growth data for AI-MED Co. in each sector below.

Source Attribution

Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.

AI-MED Co. Revenue, Valuation & Funding (2026)